Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro

Elisha Johnston; Chandrakanth Emani; Andrew Kochan; Kidane Ghebrehawariat; John Tyburski; Michael Johnston; David Rabago

doi:10.1186/s40634-020-00312-z

Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro

Elisha Johnston, Chandrakanth Emani, Andrew Kochan, Kidane Ghebrehawariat, John Tyburski, Michael Johnston, David Rabago

Department of Family and Community Medicine

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Original language	English (US)
Article number	97
Journal	Journal of Experimental Orthopaedics
Volume	7
Issue number	1
DOIs	https://doi.org/10.1186/s40634-020-00312-z
State	Published - Dec 2020

All Science Journal Classification (ASJC) codes

Orthopedics and Sports Medicine

Access to Document

10.1186/s40634-020-00312-z

Cite this

@article{d1e7e5f88d5148ebbca7820236d23671,

title = "Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro",

author = "Elisha Johnston and Chandrakanth Emani and Andrew Kochan and Kidane Ghebrehawariat and John Tyburski and Michael Johnston and David Rabago",

note = "Funding Information: Authors thank each of the following for their respective contributions. Nam Che, MS, for facilitating the bench work and PCR/ELISA at a community laboratory. Ruth Megan Elliott, MS, for assisting in converting the raw data to statistical files and repeated close readings of the manuscript. Marisa Isaacson, PhD (Molecular Biology), and William Manley, PhD (Cell and Developmental Biology), for critical readings of the manuscript.",

year = "2020",

month = dec,

doi = "10.1186/s40634-020-00312-z",

language = "English (US)",

volume = "7",

journal = "Journal of Experimental Orthopaedics",

issn = "2197-1153",

publisher = "Springer Berlin",

number = "1",

}

TY - JOUR

T1 - Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro

AU - Johnston, Elisha

AU - Emani, Chandrakanth

AU - Kochan, Andrew

AU - Ghebrehawariat, Kidane

AU - Tyburski, John

AU - Johnston, Michael

AU - Rabago, David

N1 - Funding Information: Authors thank each of the following for their respective contributions. Nam Che, MS, for facilitating the bench work and PCR/ELISA at a community laboratory. Ruth Megan Elliott, MS, for assisting in converting the raw data to statistical files and repeated close readings of the manuscript. Marisa Isaacson, PhD (Molecular Biology), and William Manley, PhD (Cell and Developmental Biology), for critical readings of the manuscript.

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85097162439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097162439&partnerID=8YFLogxK

U2 - 10.1186/s40634-020-00312-z

DO - 10.1186/s40634-020-00312-z

M3 - Article

C2 - 33280075

AN - SCOPUS:85097162439

SN - 2197-1153

VL - 7

JO - Journal of Experimental Orthopaedics

JF - Journal of Experimental Orthopaedics

IS - 1

M1 - 97

ER -

Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this